Cargando…
Development and validation of prognostic nomograms in patients with gallbladder mucinous adenocarcinoma: A population-based study
BACKGROUND: Gallbladder mucinous adenocarcinoma (GBMAC) is an uncommon malignant gallbladder tumor. There are few studies on its prognosis, with the majority consisting of small series or individual cases. We sought to develop and validate nomograms for predicting overall survival (OS) and cancer-sp...
Autores principales: | Xu, Xiaoming, Wang, Jingzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795173/ https://www.ncbi.nlm.nih.gov/pubmed/36591489 http://dx.doi.org/10.3389/fonc.2022.1084445 |
Ejemplares similares
-
Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma
por: Wang, Zhenfeng, et al.
Publicado: (2023) -
Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients
por: Shao, Chen-ye, et al.
Publicado: (2021) -
Development and validation of a prognostic nomogram for extrahepatic bile duct adenocarcinoma
por: Zhang, Shiyao, et al.
Publicado: (2022) -
Development and validation of a population-based prognostic nomogram for primary colorectal lymphoma patients
por: Chen, Qian, et al.
Publicado: (2022) -
Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit
por: Li, Lin, et al.
Publicado: (2021)